Please assess the completion status of the following clinical trial:

Trial Title: Levosimendan and Myocardial Protection

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* age ≥18 years~* intention to perform first-time multi-vessel CABG~Exclusion Criteria:~* unstable angina~* valvular disease~* diabetes mellitus treated with sulphonylurea drugs~* renal failure~* severe hepatic disease~* severe chronic obstructive pulmonary disease~* a history of prior CABG surgery~* recent myocardial infarction (MI) within the previous month

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- L (Type: EXPERIMENTAL): None
- P (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).